Difficulty: Medium
Average Score: 86%
Practice
A 46-year-old man with HIV disease presents to clinic because of a change in the appearance of his face over the past couple of months since he started antiviral therapy. His face looks sunken, particularly in the cheeks. His arms also appear to be wasting, whereas his breast tissue seems larger. He is unsure why this occurred. What medication is most likely responsible for this patients├óÔé¼Ôäó appearance?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Ritonavir. Ritonavir is a protease inhibitor commonly used in antiretroviral therapy for HIV patients. One of the known side effects of protease inhibitors, including ritonavir, is lipodystrophy. Lipodystrophy is characterized by fat redistribution in the body, leading to sunken cheeks, wasting of the arms, and increased breast tissue, as described in the patient's presentation.
Option A) Efavirenz is a non-nucleoside reverse transcriptase inhibitor and is not associated with the specific lipodystrophy changes seen in the patient.
Option B) Enfuvirtide is a fusion inhibitor and does not typically cause the fat redistribution patterns observed in the patient.
Option C) Nevirapine is a non-nucleoside reverse transcriptase inhibitor and is not linked to the lipodystrophy effects seen in the patient.
Educationally, understanding the side effect profiles of different antiretroviral drugs is crucial for healthcare providers managing HIV patients. Recognizing the association between ritonavir and lipodystrophy can guide clinicians in monitoring and managing these side effects effectively to improve patient care and quality of life.
Option A) Efavirenz is a non-nucleoside reverse transcriptase inhibitor and is not associated with the specific lipodystrophy changes seen in the patient.
Option B) Enfuvirtide is a fusion inhibitor and does not typically cause the fat redistribution patterns observed in the patient.
Option C) Nevirapine is a non-nucleoside reverse transcriptase inhibitor and is not linked to the lipodystrophy effects seen in the patient.
Educationally, understanding the side effect profiles of different antiretroviral drugs is crucial for healthcare providers managing HIV patients. Recognizing the association between ritonavir and lipodystrophy can guide clinicians in monitoring and managing these side effects effectively to improve patient care and quality of life.